Chromosome 2 (2p16) abnormalities in Carney complex tumours

Journal of Medical Genetics

Volumn 40, Issue 4, 2003, Pages 268-277

  Matyakhina, L ^a,e   Pack, S ^b   Kirschner, L S ^a   Pak, E ^c   Mannan, P ^b   Jaikumar, J ^b   Taymans, S E ^a   Sandrini, F ^a   Carney, J A ^d   Stratakis, C A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d MAYO CLINIC   (United States)

^e INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL TUMOR; AMPLICON; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOGENESIS; CARNEY COMPLEX; CENTROMERE; CHROMOSOME 17Q; CHROMOSOME 2P; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; ENDOCRINE TUMOR; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE INACTIVATION; GENE MAPPING; GENE MUTATION; GENETIC MARKER; HUMAN; HUMAN TISSUE; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PRKAR1A GENE; TELOMERE; THYROID CANCER; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; CELL CULTURE; CHROMOSOME 2; CHROMOSOME DELETION; COMPARATIVE STUDY; CONTIG MAPPING; FEMALE; GENETICS; MALE; METHODOLOGY; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE MALFORMATION SYNDROME; MYXOMA; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PIGMENT DISORDER; SYNDROME;

BACTERIA (MICROORGANISMS); NOTOLABRUS CELIDOTUS;

MICROSATELLITE DNA;

ABNORMALITIES, MULTIPLE; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 2; CONTIG MAPPING; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROSATELLITE REPEATS; MULTIPLE ENDOCRINE NEOPLASIA; MYXOMA; NUCLEIC ACID HYBRIDIZATION; PIGMENTATION DISORDERS; SYNDROME; TUMOR CELLS, CULTURED;

EID: 0037389713     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.40.4.268     Document Type: Article

References (48)

1. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivlty. Medicine 1985;64:270-83.
2. Carney JA, Hruska LS, Beauchamp GD, Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc 1986;61:165-72.
3. Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996;97:699-705.
4. Casey M, Mah C, Merliss AD, Kirschner LS, Taymans SE, Denio AE, Korf B, Irvine AD, Hughes A, Carney JA, Stratakis CA, Basson CT. Identification of o novel genetic locus for familial cardiac myxomos and Carney complex. Circulation 1998;98:2560-6.
5. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92.
6. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Strotakis CA. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet 2000;9:3037-46.
7. Taymans SE, Kirschner LS, Giotzakis C, Stratakis CA. Radiation hybrid mapping of chromosomal region 2p 15-p 16: integration of expressed and polymorphic sequences maps at the Carney complex (CNC) and Doyne honeycomb retinal dystrophy (DHRD) loci. Genomics 1999;56:344-9.
8. Kirschner LS, Taymans SE, Pack S, Pak E, Pike BL, Chandrasekharappa SC, Zhuang Z, Stratakis CA. Genomic mapping of chromosomal region 2plS-p21 (D2S378-D2S391): integration of Genemap'98 within a framework of yeast and bacterial artificial chromosomes. Genomics 1999;62:21-33.
9. Stratakis CA, Taymans SE. Structure of the gene coding for calcineurin B (PPP3R1) and mapping to D2S358-D2S1778 (chromosomal region 2p15). DNA Seq 1998;9:227-30.
10. Torttelin EE, Kirschner LS, Bellingham J, Baffi J, Taymans SE, Gregory-Evans K, Csaky K, Stratakis CA, Gregory-Evans CY. Cloning and characterization of a novel orphan G-protein-coupled receptor localized to human chromosome 2p16. Biochem Biophys Res Commun 1999;260:174-80.
11. Kirschner LS, Stratakis CA. Structure of the human ubiquitin fusion gene Uba80 (RPS27a) and one of its pseudogenes. Biochem Biophys Res Commun 2000;270:1106-10.
12. Chen X, Knauf JA, Gonsky R, Wang M, Lai EH, Chissoe S, Fagin JA, Korenberg JR. From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial.chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization. Am J Hum Genet 1998;63:625-37.
13. Hemminki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist AM, Knuutila S, Salovaara R, Bodmer W, Shibata D, de la Chapelle A, Aaltonen LA. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 1997;15:87-90.
14. Gordon KB, Thompson CT, Char DH, O'Brien JM, Kroll S, Ghazvini S, Gray JW. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res 1994;54:4764-8.
15. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol 1997;15:2894-904.
16. Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B. Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions. Genes Chrom Cancer 1995;14:155-63.
17. Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C, Theillet C. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res 1997;57:4360-7.
18. Tsuda H, Akiyama F, Terasaki H, Hasegawa T, Kurosumi M, Shimadzu M, Yamamori S, Sokamoto G. Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression. Cancer 2001;92:2965-74.
19. Couch FJ, Wang XY, Wu GJ, Qian J, Jenkins RB, James CD. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer. Cancer Res 1999;59:1408-11.
20. Gisselsson D, Palsson E, Hoglund M, Domanski H, Mertens F, Pandis N, Sciol R, Dal Cin P, Bridge JA, Mandahl N. Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma. Genes Chrom Cancer 2002;33:133-40.
21. Jin YT, Myers J, Tsai ST, Goepfert H, Batsakis JG, el Naggar AK. Genetic alterations in oral squamous cell carcinoma of young adults. Oral Oncol 1999;35:251-6.
22. Shuster MI, Han L, Le Beau MM, Davis E, Sawicki M, Lese CM, Park NH, Colicelli J, Gollin SM. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chrom Cancer 2000;28:153-63.
23. O'Neill S, Ekstrom L, Lastowska M, Roberts P, Brodeur GM, Kees UR, Schwab M, Bown N. MYCN amplification and 17q in neuroblastoma: evidence for structural association. Genes Chrom Cancer 2001;30:87-90.
24. George DL, Scott AF, de Martinville B, Francke U. Amplified DNA in Y1 mouse adrenal tumor cells: isolation of cDNAs complementary to an amplified c-Ki-ras gene and localization of homologous sequences to mouse chromosome 6. Nucleic Acids Res 1984;12:2731-43.
25. Amler LC, Schwab M. Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA. Oncogene 1992;7:807-9.
26. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
27. Pack SD, Karke'a JD, Zhuang Z, Pak ED, Balan KV, Hwu P, Park W-S, Pham T, Ault DO, Glaser M, Liotta L, Detera-Wadleigh SD, Wadleigh RG. Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chrom Cancer 1999;25:160-8.
28. Houldsworth J, Chaganti RSK. Comparative genomic hybridization: an overview. Am J Pathol 1994;145:1253-60.
29. Figureido BC, Stratakis CA, Sandrini R, DeLacerda L, Pianovsky MAD, Giatzakis C, Young HM, Haddad BR. Comparative genomic hybridization (CGH) analysis of adrenocortical tumors in childhood. J Clin Endocrinol Metab 1999;84:1116-21.
30. Kirschner LS, Stratakis CA. Large-scale preparation of sequence-ready bacterial artificial chromosome DNA using QIAGEN columns. Biotechniques 1999;27:72-4.
31. Pack SD, Zbar B, Pak E, Ault DO, Humphrey JS, Pham T, Hurley K, Weil RJ, Park WS, Kuzmin I, Stolle C, Glenn G, Liotta LA, Lerman MI, Kausner RD, Linehan WM, Zhuang Z. Constitutional van Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Res 1999;59:5560-4.
32. Steinarsdottir M, Petursdottir I, Snorradottir S, Eyfjord JE, Ogmundsdottir HM. Cytogenetic studies of breast carcinomas: different karyotypic profiles detected by direct harvesting and short-term culture. Genes Chrom Cancer 1995;13:239-48.
33. Bettio D, Giardino D, Rizzi N, Riva P, Volpi L, Barantani E, Tagliaferri A, Larizza L. Isochromosome 15q of maternal origin in a Prader-Willi patient with pituitary adenoma. Acta Genet Med Gemellol (Roma) 1996;45:213-16.
34. Tibiletti MG, Bernasconi B, Furlan D, Riva C, Trubia M, Buraggi G, Franchi M, Bolis P, Mariani A, Frigerio L, Capella C, Taramelli R. Early involvement of 6q in surface epithelial ovarian tumors. Cancer Res 1996;56:4493-8.
35. Stratakis CA, Jenkins RB, Pras E, Mitsiadis CS, Raft SB, Stalboerger PG, Tsigos C, Carney JA, Chrousos GP. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomos, spotty skin pigmentation, and endocrine overactivity (Carney complex). J Clin Endocrinol Metab 1996;81:3607-14.
36. Dewald GW, Dahl RJ, Spurbeck JL, Carney JA, Gordon H. Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas. Mayo Clin Proc 1987;62:558-67.
37. Richkind KE, Wason D, Vidaillet HJ. Cardiac myxoma characterized by clonal telomeric association. Genes Chrom Cancer 1994;9:68-71.
38. Zhuang Z, Park WS, Pack S, Schmidt L, Vortmeyer AO, Pak E, Pham T, Weil PJ, Candidus S, Lubensky IA, Linehan WM, Zbar B, Weirich G. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat Genet 1998;20:66-9.
39. Huang SC, Koch CA, Vortmeyer AO, Pack SD, Lichtenauer UD, Mannan P, Lubensky IA, Chrousos GP, Gagel RF, Pacak K, Zhuang Z. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Res 2000;60:6223-6.
40. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 1997;89:215-25.
41. Hecht F, Ramesh KH, Lockwood DH. A guide to fragile sites on human chromosomes. Cancer Genet Cytogenet 1990;44:37-45.
42. Simonic I, Gericke GS. The enigma of common fragile sites. Hum Genet 1996;97:524-31.
43. Richards RI. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet 2001;17:339-45.
44. Yunis JJ, Soreng AL. Constitutive fragile sites and cancer. Science 1984;226:1199-204.
45. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97.
46. Sozzi G, Veronese ML, Negrini M. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 1996;85:17-26.
47. Auer RL, Jones C, Mullenbach RA, Syndercombe-Court D, Milligan DW, Fegan CD, Cotter FE. Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia. Blood 2001;97:509-15.
48. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001;86:4041-6.